THBS1 rs2229691: The Asn700Ser Variant Explained
The rs2229691 polymorphism is a missense variant located in the THBS1 gene, leading to an asparagine-to-serine amino acid substitution at position 700 (Asn700Ser). This alteration affects the calcium-binding properties and structural stability of thrombospondin-1, an extracellular glycoprotein involved in vascular remodeling and platelet biology. Although early candidate-gene studies linked the variant to premature coronary artery disease, overall evidence remains limited and mixed across broader populations.
What each genotype means
Typical THBS1 profile
This genotype represents the most common form of the THBS1 gene at this position. Research indicates that individuals with this profile do not carry the specific N700S variant associated with altered calcium binding and potential coronary artery disease risk. This is considered the baseline genetic state for this variant.
This is the most frequent genotype observed across all major global populations.
Increased risk variant carrier
You carry one copy of the N700S variant, which has been studied for its potential role in early-onset coronary artery disease. Some research suggests this variant may alter thrombospondin-1 function, though the overall evidence linking it to clinical disease remains limited and may vary by ancestry. You should discuss your cardiovascular health and family history with your healthcare provider.
This genotype is found at low to moderate frequencies, typically appearing in roughly 10% to 25% of individuals depending on their ancestral background.
Elevated risk variant carrier
You carry two copies of the N700S variant, which has been identified in studies as a potential risk factor for familial premature myocardial infarction. Because this variant may affect how the body manages cell-to-matrix interactions, it is important to monitor cardiovascular health markers. Please consult with a physician to discuss how this finding fits into your broader health profile.
This genotype is relatively uncommon and is observed at lower frequencies compared to the heterozygous state across most global populations.
Molecular Mechanics: What rs2229691 Does
The single nucleotide polymorphism rs2229691 represents an A to G transition in the coding sequence of the THBS1 gene. This nucleotide alteration causes a substitution of asparagine with serine at amino acid position 700 (p.Asn700Ser) of the mature thrombospondin-1 peptide. Position 700 sits within a conserved type 3 calcium-binding repeat of the protein. Structural biology investigations, including crystallographic studies deposited in the Protein Data Bank (PDB 2RHP), show that swapping asparagine for serine subtly disrupts local calcium coordination. Because calcium ions are critical for the folding and stability of thrombospondin-1, this alteration induces both local and long-range structural changes in the protein without causing complete loss of function. Classified in standard clinical repositories such as ClinVar and UniProtKB as benign or of uncertain clinical significance, it represents a common, tolerated missense polymorphism rather than a severe monogenic mutation.
Biological Role: Thrombospondin-1 in the Vasculature
The THBS1 gene provides the blueprint for thrombospondin-1, an adhesive, multifunctional matricellular glycoprotein. It is synthesized by vascular smooth muscle cells, endothelial cells, fibroblasts, and platelets, where it is concentrated in alpha-granules and released upon activation. Thrombospondin-1 interacts with cell-surface receptors like CD36 and integrins to regulate angiogenesis, cellular adhesion, extracellular matrix homeostasis, and inflammation. Because thrombospondin-1 influences platelet aggregation, nitric oxide signaling, and vascular remodeling, researchers have long hypothesized that subtle constitutional differences in its structure could modulate vascular pathology. Animal models lacking Thbs1 exhibit altered wound healing and inflammatory responses, reinforcing the protein's critical role in maintaining vascular integrity following acute injury or continuous hemodynamic stress.
Research Associations: Coronary Artery Disease and Evidence Strength
Initial candidate-gene studies in the early 2000s identified rs2229691 as a candidate risk factor for premature coronary artery disease (CAD) and familial myocardial infarction. Researchers observed that the G allele occurred with higher frequency among individuals diagnosed with early-onset arterial thrombosis. However, subsequent large-scale genome-wide association studies (GWAS) and systematic meta-analyses in broader populations have produced mixed results, often failing to replicate the strong effect sizes reported in early cohorts. As cataloged in scientific reviews and curated genetic databases, the current evidence linking rs2229691 directly to cardiovascular events is categorized as limited. The variant may act as a low-penetrance background factor or genetic modifier rather than an independent driver of vascular disease.
Global Allele Frequencies and Ancestry Patterns
Unlike rare pathogenic mutations that cause Mendelian cardiovascular syndromes, rs2229691 is a common variant observed throughout global populations. Comprehensive sequencing data from resources like the Genome Aggregation Database (gnomAD) and dbSNP indicate that the minor G allele (encoding serine) typically circulates at frequencies between 5% and 15%, depending on the ancestral background of the cohort. In European populations, the minor allele frequency hovers around 8% to 10%, meaning that approximately 15% to 20% of European individuals carry at least one copy of the variant. The common presence of this missense change across diverse geographic ancestries supports the classification of rs2229691 as a natural human polymorphism rather than a severe, highly disruptive mutation.
Navigating Your Genetic Results Responsibly
Identifying the rs2229691 genotype on a personal genomic report cannot be used to diagnose cardiovascular disease, nor does it guarantee that heart disease will develop. Early-onset coronary artery disease is a complex, multifactorial condition driven by hundreds of common genetic loci combined with foundational lifestyle and environmental factors. Traditional cardiovascular risk factors—including blood pressure, lipid profiles, smoking status, systemic inflammation, and dietary habits—have far more predictive and clinical significance than any single candidate SNP. Genetic data regarding rs2229691 should be viewed as an educational window into human biological variation. Any personal concerns regarding cardiovascular health, family history of early heart disease, or preventive lifestyle modifications should always be evaluated in partnership with a qualified healthcare professional.
How common is this variant?
The minor G allele of rs2229691 is found globally at low to moderate frequencies, typically ranging between 0.05 and 0.15 depending on ancestry, with frequencies around 8% to 10% in European cohorts.
Frequently asked questions
Does having the rs2229691 G allele mean I will develop heart disease?
No. Carrying the G allele is not a medical diagnosis and does not cause heart disease on its own. Coronary artery disease is complex, influenced by hundreds of genetic variants alongside traditional risk factors like cholesterol, diet, and blood pressure.
What is the biochemical effect of the Asn700Ser change?
The Asn700Ser substitution replaces an asparagine residue with a serine residue in the calcium-binding domain of thrombospondin-1. Structural studies show this substitution alters local calcium ion coordination and protein stability.
Why is the evidence for rs2229691 categorized as limited?
Early candidate-gene studies suggested an association with premature myocardial infarction, but larger modern genome-wide association studies have shown mixed or non-significant results. Because the findings lack consistent large-scale replication, the clinical evidence remains limited.
Should I make lifestyle or medical changes based on this variant?
No specific medical intervention or medication dosing is guided by rs2229691. Standard evidence-based cardiovascular health habits—such as regular exercise, a balanced diet, and routine medical checkups—remain the best strategy for managing heart health.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2229691?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29